Clinical Research Directory
Browse clinical research sites, groups, and studies.
ProsTIC Registry of Men Treated With PSMA Theranostics
Sponsor: Peter MacCallum Cancer Centre, Australia
Summary
This is a descriptive, observational, prospective, open-ended, registry utilising electronic data capture to collect information on the outcomes of men treated with prostate specific-membrane antigen (PSMA) theranostics.
Official title: Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC) Prospective Patient Registry of Men Treated With PSMA Theranostics
Key Details
Gender
MALE
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
500
Start Date
2021-05-01
Completion Date
2028-12-31
Last Updated
2025-05-30
Healthy Volunteers
No
Interventions
177Lu-PSMA
Lu-PSMA will be administered as a standard-of-care procedure following assessment of suitability by a nuclear medicine physician and managed in close collaboration with the patient's medical oncologist.
Locations (1)
Peter MacCallum Cancer Centre
Melbourne, Victoria, Australia